Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of TPV/r on ZDV-TP and CBV-TP concentrations
NCT02229760Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Primary endpoints: Area under curve of intracellular Zidovudine Triphosphate and Area under curve of intracellular Carbovir Triphosphate. Started Aug 2006; status: terminated.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02229760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229760.